STILPHOSTROL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Stilphostrol, and when can generic versions of Stilphostrol launch?
Stilphostrol is a drug marketed by Bayer Pharms and is included in one NDA.
The generic ingredient in STILPHOSTROL is diethylstilbestrol diphosphate. There are twenty-six drug master file entries for this compound. Additional details are available on the diethylstilbestrol diphosphate profile page.
Summary for STILPHOSTROL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 42 |
Patent Applications: | 3,657 |
Formulation / Manufacturing: | see details |
DailyMed Link: | STILPHOSTROL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for STILPHOSTROL
US Patents and Regulatory Information for STILPHOSTROL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Pharms | STILPHOSTROL | diethylstilbestrol diphosphate | INJECTABLE;INJECTION | 010010-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bayer Pharms | STILPHOSTROL | diethylstilbestrol diphosphate | TABLET;ORAL | 010010-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |